Day: February 24, 2022

Erick Thohir Paves the way for Good Corporate Governance

JAKARTA, Indonesia, Feb. 24, 2022 /PRNewswire/ — Good corporate governance (GCG) can help state-owned enterprises (SOEs) increase their value, investor confidence, develop their businesses, and manage risks. Therefore, SOEs must implement GCG to fulfill their responsibility to the country, their shareholders, and the public, according to analysts. GCG involves regulating, managing, and supervising a sustainable […]

Read More . .

‫أوبو تستعد لتعزيز تواجدها في سوق الهواتف الرائدة بإطلاق سلسلة “فايند إكس5” الجديدة

–  تتميز سلسلة هواتف “فايند إكس5” الرائدة بتصميمات جمالية مستقبلية تحقق بُعداً عصرياً وصديقاً للبيئة وتجارب تصوير مُبتكرة هي الأولى من نوعها في العالم دبي، الإمارات العربية المتحدة, 24 فبراير / شباط 2022 /PRNewswire/ — –أعلنت أوبو اليوم، عن أحدث مجموعة من الهواتف الذكية الرائدة “سلسلة هواتف فايند إكس5″ والتي تعد بمثابة قفزة نوعية في سوق الهواتف الرائدة للعلامة التجارية العالمية. إن […]

Read More . .

Provation appoints Gulf Medical Company as exclusive partner in Saudi Arabia for its market-leading clinical productivity solution

Provation® MD allows clinicians around the world to quickly and accurately document procedures electronically for gastroenterology and respiratory procedures. Jeddah, Saudi Arabia, and Minneapolis, Minn., USA, Feb. 24, 2022 (GLOBE NEWSWIRE) — Provation, the premier software provider of procedure documentation and clinical decision support solutions, today announced an exclusive partnership with Gulf Medical Company, Ltd., […]

Read More . .

Seegene unveils new assay optimized for on-site testing in ‘living with Covid-19’ era

Test can deliver results within 30 minutes, boosting testing capacity up to 5-fold Optimal for on-site testing at large-scale facilities such as schools, airports Accuracy near to RT-PCR tests  even for asymptomatic patients “Reasonable price to allow easy and swift testing for anybody” SEOUL, South Korea, Feb. 24, 2022 /PRNewswire/ — Seegene Inc. (KQ 096530), South […]

Read More . .